Centchroman Regress Mastalgia and Fibroadenoma: An Institutional Study
Journal Title: Journal of Medical Science And clinical Research - Year 2016, Vol 4, Issue 7
Abstract
Objectives: Centchroman (also known as Ormeloxifene) is one of the selective estrogen receptor modulators, or SERMs, a class of medication which acts selectively on the estrogen receptor. Because of its selective antiestrogen action, centchroman has been used for treatment of mastalgia and fibroadenoma. Materials And Methods: Benign breast disease patients up to 35 years of age attending surgery outpatient department from August 2012 to September 2014 and fulfilling inclusion criterion were included in the study. The patients were started on centchroman 30 mg on daily for a period of 12 weeks and were followed at weeks 4, 8, 12, and 24 to assess response to therapy. The Results were recorded as per clinical examination, ultrasonography for breast lump size and visual analog scale (VAS) for pain. Results: A total of 130 patients were included in the study, 88 (67.70%) of whom had mastalgia with or without nodularity, and 42 (32.30%) had fibroadenoma. Noncyclical pain was in 71 patients (80.70%), and cyclical pain was recorded in only 17 (19.30%) patients. A VAS score of 10 was recorded by 62 (70.50%) patients (severe pain), and the remaining 26 patients (29.50%) had VAS score from 7 to 10. Fibroadenoma size ranged from 1.5 to 5 cm, single or multiple in one or both breast. There was a good response in the mastalgia group, with a decrease in the VAS scoring from 10 to 3 in 69 (78.40%) of the patients in the first week. Almost all of the patients were painless at the end of first month, with complete disappearance of the nodularity. In the fibroadenoma group there was a mixed response, with complete disappearance in 21 (35%), partial regression (decrease in volume of fibroadenoma) in 29 (48.30%) and no response at all in the remaining 10 (16.70%) a period of 6 months. There were few side effects with scanty menses or amenorrhea as the only side effect. Conclusions: Centchroman is a safe drug for the treatment of mastalgia and fibroadenoma. It has shown good results in mastalgia and fibroadenoma, is an effective, safe and inexpensive
Authors and Affiliations
Bhupender Sharma
Keywords
Related Articles
- EP ID EP213807
- DOI -
- Views 69
- Downloads 0
Anticipatory Postural Adjustment of the Core Muscles during Forward Arm Reaching in Children with Spastic Diplegia
Background: Children with cerebral palsy (CP) have disorders of the development of movement and posture, and they may have difficulties achieving trunk control. Trunk control is essential for free and selective movements...
FNAC Vs Histopathology in the Diagnosis of Thyroid Swellings
Background: Fine Needle Aspiration Cytology (FNAC) is important for pre-operative and pre-treatment diagnosis of benign and malignant thyroid lesions, thus decreasing the incidence of unwanted surgeries. FNAC of thyroid...
Challenges of Manpower Problems and Its Solution (With special reference to Public health sector)
This review research paper has examined about the current circumstances of human resource in public health sectors. A recent trend of manpower planning says that there is necessity of improving the system of manpower pla...
Prescription audit and assessment of drug use pattern using World Health Organization prescribing indicators in a tertiary care teaching and referral hospital in Himachal Pradesh, India
Background: The quality of a prescription reveals the attitude of the prescriber towards rational prescribing. Rational use of drugs is an essential element in achieving high quality patient care. This study aims to audi...
Evaluation of Best Marker in the Diagnosis of Various Liver Diseases
The liver has a central & critical bio-chemical role in metabolism, digestion, detoxification & elimination of substances from the body. All blood from the intestinal tract initially passes through the liver, where produ...